MRETDIM • 5366
WU College of Nursing — PMHNP Program
E D U C AT I O N F O R G O O D
EST. 1970
NRNP 6635 — Midterm Examination
P SYC H O P H A R M A CO LO G Y, N E U R O B I O LO G Y & T H E R A P E U T I C F R A M E W O R K S
INSTITUTION Walden University EXAM CODE NRNP-6635-MID-2026
PROGRAM MSN/PMHNP — Psychiatric-Mental Health ACADEMIC YEAR
Nurse Practitioner
EXAM TITLE NRNP 6635 Midterm Examination TOTAL QUESTIONS 25 Questions
COURSE TITLE Psychopharmacology & Neurobiology for FORMAT Multiple Choice — Select the Single Best
PMHNP Answer
EXAMINATION INSTRUCTIONS
▸ Select the single best answer for each question.
▸ Questions cover neurobiology of mental disorders, neurotransmitter systems, psychopharmacology mechanisms, brain
structure/function, developmental theories, cognitive-behavioral frameworks, therapeutic communication, and mental status
examination.
▸ Distinguish carefully between neurotransmitter roles (serotonin, dopamine, GABA, norepinephrine), brain region functions, and
medication mechanisms.
▸ Correct answers and detailed rationales appear below each question for comprehensive review.
▸ All content is derived from NRNP 6635 Midterm examination curriculum.
SECTION I — NEUROBIOLOGY, PSYCHOPHARMACOLOGY & THERAPEUTIC Questions 1 –
FRAMEWORKS 25
1. Why do mental health disorders occur biologically?
A. They result purely from emotional dysregulation without brain involvement
B. Mental disorders result from dysfunction in brain circuits — genetics create vulnerability, and stress/environment
activate abnormal signaling between neurons
C. They are caused exclusively by neurotransmitter deficiencies with no genetic component
D. Mental illness is solely a social construct without biological basis
CORRECT ANSWER B — Mental disorders result from dysfunction in brain circuits — genetics create vulnerability, and
stress/environment activate abnormal signaling between neurons
RATIONALE Mental disorders follow the biopsychosocial model: genetic predisposition creates vulnerability, and
environmental stressors trigger abnormal neural circuit functioning. Neurotransmitters fire either too much
or too little, disrupting mood, thinking, and behavior. This is not purely emotional (Option A) or purely
environmental — it involves measurable brain circuit dysfunction.
, 2. How does serotonin affect mood and anxiety?
A. Serotonin increases dopamine release, directly causing euphoria
B. Serotonin helps regulate emotional stability, sleep, appetite, and impulse control — when signaling is low, emotional
responses become exaggerated
C. Serotonin only affects gastrointestinal function and has no role in mood
D. Serotonin blocks GABA receptors, causing heightened anxiety
CORRECT ANSWER B — Serotonin helps regulate emotional stability, sleep, appetite, and impulse control — when
signaling is low, emotional responses become exaggerated
RATIONALE Serotonin (5-HT) is a monoamine neurotransmitter critical for emotional regulation. Low serotonergic
signaling produces clinical signs of depression, anxiety, irritability, and obsessive thinking. SSRIs work by
blocking serotonin reuptake (SERT transporter), increasing synaptic serotonin availability, and strengthening
neuronal signaling — leading to improved emotional regulation over 4–6 weeks.
3. Why does excess dopamine cause psychosis?
A. Dopamine directly damages brain tissue, causing hallucinations
B. Dopamine assigns importance ("salience") to experiences — excess in the mesolimbic pathway makes neutral events
feel meaningful or threatening, resulting in hallucinations, paranoia, and delusions
C. Dopamine decreases all brain activity, producing sensory deprivation
D. Dopamine has no relationship to psychotic symptoms
CORRECT ANSWER B — Dopamine assigns importance ("salience") to experiences — excess in the mesolimbic pathway
makes neutral events feel meaningful or threatening
RATIONALE The dopamine hypothesis of schizophrenia centers on the salience pathway: excess dopamine in the
mesolimbic tract (VTA → nucleus accumbens) causes neutral stimuli to be tagged as highly significant or
threatening, producing hallucinations, paranoia, and delusions. Antipsychotics block D2 receptors, reducing
this aberrant salience signaling and improving reality perception.
4. Why do schizophrenia patients experience negative symptoms?
A. Excess dopamine in all brain regions causes emotional blunting
B. Low dopamine in the mesocortical pathway affects the prefrontal cortex, reducing motivation and emotional
expression
C. Negative symptoms are purely psychological and have no biological basis
D. Serotonin excess in the prefrontal cortex causes social withdrawal
CORRECT ANSWER B — Low dopamine in the mesocortical pathway affects the prefrontal cortex, reducing motivation and
emotional expression
RATIONALE Schizophrenia involves a dopamine imbalance: excess in mesolimbic (positive symptoms) and deficit in
mesocortical (negative symptoms). Low dopamine in the mesocortical pathway (VTA → prefrontal cortex)
produces flat affect, social withdrawal, poor concentration, and avolition. Importantly, antipsychotics
primarily help positive symptoms by blocking D2 receptors — they have limited efficacy for negative
symptoms.